Marcus Björnsson, Ph.D.

Senior Consultant & Team Leader


  • Joined Pharmetheus in 2014, actively working in client projects and serving as Deputy Project Portfolio Team Leader.
  • Expertise includes pediatrics and non-compartmental analysis in therapeutic areas such as neuroscience and orphan indications.
  • Experience as Neuroscience Therapy Area Pharmacometrics Expert at AstraZeneca R&D, Sweden, where he had strategic and scientific accountability for pharmacometric activities within the neuroscience therapy area. Previously, he worked as Clinical Pharmacokineticist, Senior Research Scientist, and Senior Pharmacometrician at AstraZeneca R&D, Sweden, and Research Scientist at Astra Pain Control, Sweden.
  • M.Sc. in Pharmaceutical Sciences (1999) and Ph.D. in Pharmacokinetics and Drug Therapy (2013) from Uppsala University, Sweden.
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Development of a population pharmacokinetic model to characterize the pharmacokinetics of intrathecally administered tominersen in cerebrospinal fluid and plasmaPopulation Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use DisorderA Bolus and Bolus Followed by Infusion Study of AZD3043, an Investigational Intravenous Drug for Sedation and Anesthesia: Safety and Pharmacodynamics in Healthy Male and Female Volunteers